SoFiT: Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention

Sponsor
Wageningen University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05390398
Collaborator
World Cancer Research Fund International (Other), Gelderse Vallei Hospital (Other), Flevoziekenhuis (Other), Slingeland Hospital (Other), Rijnstate Hospital (Other), Het Prospectief Landelijk CRC cohort (PLCRC) (Other)
184
1
2
26.4
7

Study Details

Study Description

Brief Summary

The SoFiT study is a randomized controlled trial examining the effects of a behaviour change guided lifestyle intervention on increasing adherence to the World Cancer Research Fund cancer prevention guidelines, compared to the wait-list usual care group, on diminishing cancer-related fatigue in colorectal cancer survivors.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Behaviour change guided lifestyle intervention
N/A

Detailed Description

The SoFiT study is a randomized controlled trial examining the effects of a behaviour change guided lifestyle intervention on increasing adherence to the World Cancer Research Fund (WCRF) cancer prevention guidelines, compared to the wait-list usual care group, on diminishing cancer-related fatigue in colorectal cancer survivors.

Colorectal cancer survivors who completed treatment six months to two years ago and who suffer from cancer-related fatigue, are randomized into two parallel groups: an intervention group or the wait-list usual care group. The intervention group follows a six-month personalized lifestyle program, which is guided by behaviour change techniques, to increase adherence to the World Cancer Research Fund cancer prevention guidelines on healthy nutrition, physical activity and healthy weight. Participants are guided by a lifestyle coach specialized in behaviour change. The wait-list usual care group receives a lifestyle program after the intervention period of six months: this includes two personalized behavioural coaching sessions and any material that the intervention group also received.

Both groups participate in measurements at baseline, three months, at the end of the intervention (six months) and at follow-up (twelve months). The follow-up timepoint is included to study long-term behavioural lifestyle change. The primary outcome is the change in cancer-related fatigue, as measured by the FACIT-Fatigue questionnaire, between the intervention and wait-list usual care group from baseline till six months.

Secondary outcomes include cancer-related fatigue (at other timepoints), skeletal muscle fat infiltration and cross-sectional area, gut microbiota composition, health-related quality of life, physical performance, sleep quality and duration, depression and anxiety, behavioural determinants and adherence to the WCRF guidelines by assessing habitual dietary intake, physical activity level, height, weight, waist circumference and BMI. Other outcomes of interest include, blood pressure, chrono-nutrition, colorectal cancer related complaints, hemoglobin blood levels, self-reported weight (at three months) and cost-effectiveness evaluation. Moreover, the following data will be collected to characterize the population: sociodemographic information (age, sex, marital status, education, smoking) and clinical parameters (time since diagnosis, current and received treatment, comorbidities, medicine and supplement use).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
184 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trial with two parallel arms: intervention and control.Randomized controlled trial with two parallel arms: intervention and control.
Masking:
Single (Outcomes Assessor)
Masking Description:
The nature of the intervention does not allow for blinding of the participants or researchers. The baseline measurements are however blinded as both the participant and the researchers do not yet know in which group the participant will be classified. Randomization is done directly after the baseline measurements. After data collection, the database will be coded by an independent researcher to ensure that data analysis is conducted in a blinded way.
Primary Purpose:
Treatment
Official Title:
Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention
Actual Study Start Date :
Jan 18, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

The intervention group follows a six-month personalized lifestyle program to increase adherence to the World Cancer Research Fund cancer prevention guidelines on healthy nutrition, physical activity and healthy weight.

Behavioral: Behaviour change guided lifestyle intervention
Participants in the intervention group receive personalized coaching from a lifestyle coach on adhering to the World Cancer Research Fund cancer prevention guidelines. The lifestyle coach is specialized in behaviour change techniques and uses these as the core of the lifestyle coaching. For each participant behavioural determinants will be assessed and targeted with specific applicable behaviour change techniques.

No Intervention: Wait-list usual care group

The wait-list usual care group follows usual care and usual activities. Participants receive a lifestyle program after the intervention period of six months: this includes two personalized behavioural coaching sessions and any material that the intervention group also received.

Outcome Measures

Primary Outcome Measures

  1. Change in cancer-related fatigue [Baseline till six months]

    Cancer-related fatigue is assessed with the FACIT-Fatigue Scale, a 13 item questionnaire with scores ranging from 0-52. A score below 34 indicates fatigue. The minimal clinically important difference is reported to be 3.0 for this scale.

Secondary Outcome Measures

  1. Cancer-related fatigue [Twelve months]

    Cancer-related fatigue is assessed with the FACIT-Fatigue Scale, a 13 item questionnaire with scores ranging from 0-52. A score below 34 indicates fatigue. The minimal clinically important difference is reported to be 3.0 for this scale.

  2. Skeletal muscle fat infiltration and muscle circumference [Baseline and six months]

    Echo intensity of the skeletal muscle rectus femoris, lateral gastrocnemius and biceps brachialis is measured using a portable ultrasound machine.

  3. Gut microbiota composition [Baseline and six months]

    Faecal samples are collected and the microbiota composition in this will be analyzed. The investigators will use 16S rRNA sequencing data for the taxonomic characterization of the gut microbiota. Eventually shotgun sequencing may also be done.

  4. Health-related quality of life [Baseline and six months]

    Health-related quality of life is measured with the Functional Assessment of Cancer Therapy - General (FACT-G) questionnaire, which contains the following domains of well-being: physical, social/family, emotional and functional. The 27-item questionnaire has scores ranging from 0 to 108.

  5. Physical performance (3-minute step test) [Baseline and six months]

    This test indicates cardiovascular fitness by heart rate measurement for one minute after the completion of three minutes of stepping.

  6. Physical performance (5 times sit-to-stand test) [Baseline and six months]

    This test indicates lower extremity skeletal muscle strength. The time necessary to achieve the standing position on the 5th repetition is measured.

  7. Physical performance (tandem test) [Baseline and six months]

    This test measures balance for three different standing positions. Each position has to be maintained for 10 seconds in order to pass the test.

  8. Physical performance (chair sit-and-reach test) [Baseline and six months]

    This test measures lower extremity and lower back flexibility. Participants sit on a chair and bend forward and reach for their toes. The distance between the hand and toes is measured.

  9. Physical performance (strength: hand dynamometer) [Baseline and six months]

    This test uses a hand dynamometer to measure strength.

  10. Sleep quality and duration (Pittsburgh Sleep Quality Index) [Baseline, six months and 12 months]

    Sleep quality is measured with the Pittsburgh Sleep Quality Index (PSQI), a 19-item questionnaire with scores ranging from 0-21. A score above 5 indicates bad sleep quality.

  11. Sleep quality and duration (Consensus sleep diary morning) [Baseline and six months]

    The Consensus sleep diary morning (CSD), a 15-item diary, is used for measuring other sleep outcomes such as sleep onset latency and sleep duration.

  12. Depression [Baseline and six months]

    Depression is measured using the 8-item Patient Healthcare Questionnaire (PHQ-8). It contains 8 items, and scores range from 0-24, with higher scores indicating a higher chance of depression.

  13. Anxiety [Baseline and six months]

    Anxiety is measured using the 7-item Generalized Anxiety Disorder (GAD-7). The GAD-7 contains 7 items, its scores range from 0-21, with higher scores indicating a higher chance of anxiety.

  14. Behavioural determinants [Baseline, three months, six months and twelve months.]

    Identified behavioural determinants through focus groups and a systematic review, are assessed using a self-reported questionnaire with questions based on previous reported questions on different determinants. These were adapted to reflect the WCRF guidelines. Higher scores for each of the determinants (scale 1-7) indicate better results.

  15. Habitual dietary intake (Food Frequency Questionnaire) [Baseline, six months and twelve months]

    Nutritional intake is measured using a semi-quantitative Food Frequency Questionnaire (FFQ). Scores are calculated using the Dutch National Food Consumption tables. In addition, the validated questionnaire Eetscore is used, which contains a short online questionnaire (10-15 minutes) that serves as an indicator to assess diet quality, based on the Dutch Healthy Diet index 2015 (DHD15-index). Scores range from 0-160, with higher scores indicating better diet quality.

  16. Habitual dietary intake (Eetscore) [Baseline, three months, six months and twelve months]

    Nutritional intake is also measured using the validated questionnaire Eetscore, which uses a short online questionnaire (10-15 minutes) that serves as an indicator to assess diet quality, based on the Dutch Healthy Diet index 2015 (DHD15-index). Scores range from 0-160, with higher scores indicating better diet quality.

  17. Physical activity level (Short QUestionnaire to ASsess Health-enhancing physical activity) [Baseline, three months, six months and twelve months]

    Physical activity is measured using the Short QUestionnaire to ASsess Health-enhancing physical activity (SQUASH). The questions in the SQUASH are pre-structured in commuting, leisure time, household and work/school activities. Scores will be assigned to the different reported activities base on intensities in MET and translated to minutes of physical activity.

  18. Physical activity level (Accelerometer) [Baseline and six months]

    Physical activity is also measured using ActivPalTM Micro3, an accelerometer measuring sedentary behaviour and physical activity. The ActivPalTM is worn for 9 days.

  19. Anthropometric measurements (Height) [Baseline and six months]

    Height (in cm) is measured with a stadiometer.

  20. Anthropometric measurements (Weight) [Baseline, three months (self-reported) and six months]

    Weight (in kg) is measured with a calibrated scale.

  21. Anthropometric measurements (Waist circumference) [Baseline and six months]

    Waist circumference (in cm) is measured using tape measures.

  22. Cost-effectiveness evaluation [Baseline, three months and six months]

    The cost-effectiveness of the intervention is evaluated using a questionnaire that includes items on for example costs that the participant has made in order to follow the lifestyle program.

Other Outcome Measures

  1. Blood pressure [Baseline and six months]

    Blood pressure is measured using a sphygmomanometer. Both diastolic and systolic blood pressure are measured.

  2. Heart rate [Baseline and six months]

    Heart rate is measured using a sphygmomanometer.

  3. Chrono-nutrition [Baseline and six months]

    Chrono-nutrition, the timing of dietary intake, is measured with the "Chromes vragenlijst patiënten eetpatronen". This is a Dutch questionnaire containing 26 items that assess meal regularity (8-items), meal frequency (7-items), and meal clock time (11-items).

  4. Colorectal cancer related complaints [Baseline and six months]

    Measuring colorectal cancer specific problems is done using the additional concerns (i.e. subscale) of the Functional Assessment of Cancer Therapy - Colorectal (FACT-C). This questionnaire contains 9 items and scores are ranging from 0-28 points.

  5. Hemoglobin levels [Baseline and six months]

    Finger prick blood sampling is used for assessing haemoglobin status as an indicator for anaemia.

  6. Sociodemographic information [Baseline (and six months)]

    Sociodemographic information is collected using standardized questionnaires.

  7. Clinical parameters [Baseline (and six months)]

    Clinical parameters such as time since diagnosis, current and received treatment, comorbidities and medicine use, are collected either via standardized questionnaires or from medical records (part of informed consent).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged 18 or above.

  • Completed curative stage I-III colorectal cancer treatment in the previous 6 to 24 months.

  • Live on a reasonable distance from the research center at the Wageningen University & Research (WUR) (i.e. maximum of ± 1 hour away).

  • Classified as suffering from CRF through the Functional Assessment of Chronic Illness Therapy (FACIT) - Fatigue Scale questionnaire with cut-off score below 34 indicating fatigue.

  • Willingness to be randomized into either the intervention or wait-list control group.

  • Willing and able to follow the lifestyle intervention.

  • Able to understand and provide informed consent in Dutch.

Exclusion Criteria:
  • Planning to participate or participating in another medical research that could possibly interfere with the study results.

  • Excessive alcohol consumption (i.e. more than 14 units for males per week; 7 units for females per week).

  • Chronic drug use and unwillingly to stop using drugs.

  • Unable/unwilling to comply with the intervention (e.g. through dementia, Alzheimer or mental illness)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Wageningen University & Research Wageningen Gelderland Netherlands 6708WE

Sponsors and Collaborators

  • Wageningen University
  • World Cancer Research Fund International
  • Gelderse Vallei Hospital
  • Flevoziekenhuis
  • Slingeland Hospital
  • Rijnstate Hospital
  • Het Prospectief Landelijk CRC cohort (PLCRC)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Wageningen University
ClinicalTrials.gov Identifier:
NCT05390398
Other Study ID Numbers:
  • NL75999.091.21
First Posted:
May 25, 2022
Last Update Posted:
May 25, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wageningen University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 25, 2022